Effect of Soybean on Alzheimer

Clinical evaluation of the effect of standard hydroalcoholic extract of soybean seeds (Glycine max L.) on Alzheimer's disease severity.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170702034861N9

Enrollment

Registered

2019-10-18

Start date

2019-07-23

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease. Other degenerative diseases of the nervous system

Interventions

Intervention 1: Intervention group: The intervention group will receive the soybean capsule. Get help with the capsule shape You can eat in your 500ml capsule every 8 hours. Intervention 2: Control gr

Eligibility

Sex/Gender

All

Age

50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age over 50 years old Having a MMSE score between 16 and 24 Lack of substance abuse and alcohol abuse Do not use anticoagulants Lack of heart disease

Exclusion criteria

Exclusion criteria: depession

Design outcomes

Primary

Measure	Time frame
Cognitive status of patients. Timepoint: 90-60-0day. Method of measurement: MMSD and CDR questionnair.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeynab Pour Ramezan

Kerman University of Medical Sciences

nakisa.1995@gmail .com+98 34 3132 5600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026